SBI-797812
| Clinical data | |
|---|---|
| Drug class | NAMPT activator |
| Identifiers | |
| |
| CAS Number | |
| PubChem CID | |
| ChemSpider | |
| ChEMBL | |
| Chemical and physical data | |
| Formula | C19H22N4O4S |
| Molar mass | 402.47 g·mol−1 |
| 3D model (JSmol) | |
| |
| |
SBI-797812, is a drug which acts as a selective activator of the enzyme nicotinamide phosphoribosyltransferase (NAMPT). It increases the rate of nicotinamide mononucleotide production by NAMPT and decreases feedback inhibition by NAD+. It has been researched for application as a potential anti-aging drug.[1][2]
See also
References
- ^ Gardell SJ, Hopf M, Khan A, Dispagna M, Hampton Sessions E, Falter R, et al. (July 2019). "Boosting NAD+ with a small molecule that activates NAMPT". Nature Communications. 10 (1) 3241. Bibcode:2019NatCo..10.3241G. doi:10.1038/s41467-019-11078-z. PMC 6642140. PMID 31324777.
- ^ Khaidizar FD, Bessho Y, Nakahata Y (April 2021). "Nicotinamide Phosphoribosyltransferase as a Key Molecule of the Aging/Senescence Process". International Journal of Molecular Sciences. 22 (7): 3709. doi:10.3390/ijms22073709. PMC 8037941. PMID 33918226.